Vincent Rajkumar: 2024 Update on multiple myeloma
Vincent Rajkumar shared on X:
“2024 update on multiple myeloma is available open access!
Latest ASCO24 data. Treatment algorithms.
Approach to newly diagnosed myeloma.
Approach to Relapsed Myeloma.
Update on Immunotherapy for myeloma.
All the essentials of myeloma in one paper. Includes diagnostic criteria, risk stratification, prognosis, supportive care, and recommended real world dosing schedules for commonly used regimens.
Myeloma treatment dosing differs often from what was published in the original trials.”
Source: Vincent Rajkumar/X
Vincent Rajkumar is a Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group. He also chairs the Board of directors of The International Myeloma Foundation and the Eastern Cooperative Oncology Group (ECOG) Myeloma Committee.
His extensive contributions include over 230 peer-reviewed publications, predominantly focusing on multiple myeloma and related plasma cell disorders. Furthermore, Dr. Rajkumar is a Section Editor for multiple myeloma and related disorders for Leukemia and an Associate Editor for the Mayo Clinic Proceedings.
Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management.
Author: Vincent Rajkumar
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023